Trial Profile
A study to evaluate EMI-137 for the diagnosis of patients with pancreatic cancer
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 25 Feb 2017
Price :
$35
*
At a glance
- Drugs EMI-137 (Primary)
- Indications Pancreatic cancer
- Focus Diagnostic use
- 25 Feb 2017 New trial record